Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer

Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer

(2010) Alberto A. Chiappori et al.   Journal of Thoracic Oncology

Quantitative Analysis of Tumor in Bronchial Biopsy Specimens

(2010) Caroline L. Coghlin et al.   Journal of Thoracic Oncology

Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

(2008) C. L. Hann et al.   CANCER RESEARCH

Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models

(2008) A. R. Shoemaker et al.   CLINICAL CANCER RESEARCH

Tissue microarrays: emerging standard for biomarker validation

(2008) Saima Hassan et al.   CURRENT OPINION IN BIOTECHNOLOGY

Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

(2008) Charles M. Rudin et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer

(2007) Hyun Woo Lee et al.   LUNG CANCER